FREQUENT DISEASE RELAPSE AFTER WITHDRAWAL OF INFLIXIMAB IN IBD PATIENT WITH SUSTAINED REMISSION

被引：0
|
作者：
Gordon, Hannah [1 ]
Murray, Jennifer [1 ]
Tailor, Falguni [1 ]
Goh, Sean [1 ]
Lindsay, James O. [1 ]
机构：
[1] Royal London Hosp, London, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P104
引用
收藏
页码：A95 / A95
页数：1
相关论文
共 50 条
  • [31] Impact of patient education on switch acceptance in IBD patients in remission, with infliximab originator switched for an infliximab biosimilar: a prospective study
    Hastier-De Chelle, A.
    Cluzeau, V.
    Condat, J.
    Arab, N.
    Hebuterne, X.
    Filippi, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S386 - S386
  • [32] Serology Panel for Prediction of Relapse After Discontinuation of Infliximab in Patients With Crohn's Disease Achieving Clinical Remission
    Papamichael, Konstantinos
    Claes, Karolien
    de Bruyn, Magali
    Princen, Fred
    Singh, Sharat
    Van Assche, Gert A.
    Rutgeerts, Paul J.
    Vermeire, Severine
    Ferrante, Marc
    Hauenstein, Scott
    GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865
  • [33] IMPACT OF PATIENT EDUCATION ON SWITCH ACCEPTANCE IN IBD PATIENTS IN REMISSION, WITH INFLIXIMAB ORIGINATOR SWITCHED FOR AN INFLIXIMAB BIOSIMILAR: A PROSPECTIVE STUDY
    Hastier-De Chelle, Audrey
    Cluzeau, Virginie
    Condat, Joris
    Arab, Nadia
    Hebuterne, Xavier
    Filippi, Jerome
    GASTROENTEROLOGY, 2019, 156 (06) : S955 - S956
  • [34] Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
    Kennedy, N. A.
    Kalla, R.
    Warner, B.
    Gambles, C. J.
    Musy, R.
    Reynolds, S.
    Dattani, R.
    Nayee, H.
    Felwick, R.
    Harris, R.
    Marriott, S.
    Senanayake, S. M.
    Lamb, C. A.
    Al-Hilou, H.
    Gaya, D. R.
    Irving, P. M.
    Mansfield, J.
    Parkes, M.
    Ahmad, T.
    Cummings, J. R. F.
    Arnott, I. D.
    Satsangi, J.
    Lobo, A. J.
    Smith, M.
    Lindsay, J. O.
    Lees, C. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) : 1313 - 1323
  • [35] thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease
    Benitez, J. M.
    Garcia-Sanchez, V.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) : 494 - 495
  • [36] Deep Remission in Crohn's Disease Does Not Prevent Disease Relapse After Withdrawal of Anti-TNFα Therapy
    Duricova, Dana
    Bortlik, Martin
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Lukas, Milan
    GASTROENTEROLOGY, 2015, 148 (04) : S61 - S61
  • [37] Deep remission in Crohn's disease does not prevent disease relapse after withdrawal of anti-TNFa therapy
    Bortlik, M.
    Duricova, D.
    Machkova, N.
    Hruba, V.
    Lukas, M.
    Mitrova, K.
    Romanko, I.
    Bina, V.
    Lukas, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S4 - S4
  • [38] Sustained response in early poor prognosis RA after withdrawal of infliximab therapy
    Quinnn, MA
    Conaghan, PG
    Greenstein, A
    Karim, Z
    Brown, C
    Emery, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3416 - 3416
  • [39] Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn's Disease with no Relapse After Switching to Adalimumab
    Cravo, Marilia
    Silva, Rosa
    Serrano, Miguel
    BIODRUGS, 2010, 24 : 25 - 27
  • [40] Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn’s Disease with no Relapse After Switching to Adalimumab
    Marilia Cravo
    Rosa Silva
    Miguel Serrano
    BioDrugs, 2010, 24 : 25 - 27
12345